Effect of lavender on anxiety, depression and fatigue in hemodialysis patients

The effect of aromatherapy with lavender Essential oil on anxiety, depression and fatigue, in hemodialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201505257494N12

Enrollment

Registered

2015-12-10

Start date

2015-06-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemodialysis patient. Care involving dialysis

Interventions

Intervention 1: experimental group will be exposed to the inhalation of lavender essence produced by Barij certified pharmaceutical company with quality standards of ISO 9001 and ISO / IEC 17025. Lave

Treatment - Drugs

Patients in the control group will be received usual care

experimental group will be exposed to the inhalation of lavender essence produced by Barij certified pharmaceutical company with quality standards of ISO 9001 and ISO / IEC 17025. Lavender essence is

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patient including major criteria: at least 6 months of dialysis treatment; dialysis for 3 times a week; being over 18 years; alertness and ability to communicate; having a good sense of smell; have not a stressful event in the past 6 months; don't using sedatives drugs Patient eligibility major criteria: candidate for a transplant; pregnancy or decision to pregnancy; record of allergies; chronic respiratory diseases; addiction

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Depression and anxiety. Timepoint: Before intervention first week, second week,third week, fourth week and fifth week. Method of measurement: Hospital Anxiety and Depression Scale.;Fatigue. Timepoint: Before intervention first week, second week,third week, fourth week and fifth week. Method of measurement: Fatigue Severity Scale.;Well being. Timepoint: Before intervention first week, second week,third week, fourth week and fifth week. Method of measurement: visula Analogue scale.	—

Measure

Time frame

Depression and anxiety. Timepoint: Before intervention first week, second week,third week, fourth week and fifth week. Method of measurement: Hospital Anxiety and Depression Scale.;Fatigue. Timepoint: Before intervention first week, second week,third week, fourth week and fifth week. Method of measurement: Fatigue Severity Scale.;Well being. Timepoint: Before intervention first week, second week,third week, fourth week and fifth week. Method of measurement: visula Analogue scale.

—

Secondary

Measure	Time frame
Allergic to Lavender. Timepoint: During five weeks of intervention. Method of measurement: Questions from Patients.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAttieh Nikkhah

Mazandaran University of Medical Sciences

atinik1357@gmail.com+98 11 3337 1010

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026